ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 914,49
-0,88%
Dow Jones
37 903,29
0,23%
DAX
17 914,89
-0,04%
Brent Oil
84,075
0,64%
Bitcoin
57 619,98
-1,06%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Sunshine Biopharma Inc (SBFM)

  7. Sunshine Biopharma Inc (SBFM) Actualités

SBFM

Sunshine Biopharma (SBFM)

Sunshine Biopharma Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SBFM
DateHeureSourceTitreSymboleSociété
06/03/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SBFMSunshine Biopharma Inc
05/03/202422h37Edgar (US Regulatory)Form PRE 14C - Other preliminary information statementsNASDAQ:SBFMSunshine Biopharma Inc
05/03/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
23/02/202422h03Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SBFMSunshine Biopharma Inc
14/02/202417h18Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SBFMSunshine Biopharma Inc
13/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SBFMSunshine Biopharma Inc
09/02/202423h17Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SBFMSunshine Biopharma Inc
09/02/202414h59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SBFMSunshine Biopharma Inc
01/02/202422h17Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SBFMSunshine Biopharma Inc
08/01/202414h10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SBFMSunshine Biopharma Inc
04/12/202314h30GlobeNewswire Inc.Sunshine Biopharma Moves Principal Office to New York CityNASDAQ:SBFMSunshine Biopharma Inc
13/11/202314h00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SBFMSunshine Biopharma Inc
19/10/202318h10Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SBFMSunshine Biopharma Inc
18/10/202319h32Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
25/08/202321h16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SBFMSunshine Biopharma Inc
11/08/202314h30GlobeNewswire Inc.Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%NASDAQ:SBFMSunshine Biopharma Inc
06/06/202312h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:SBFMSunshine Biopharma Inc
05/06/202323h29Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:SBFMSunshine Biopharma Inc
25/05/202322h05Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:SBFMSunshine Biopharma Inc
17/05/202319h31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:SBFMSunshine Biopharma Inc
16/05/202315h58GlobeNewswire Inc.Sunshine Biopharma Announces Closing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
12/05/202314h00GlobeNewswire Inc.Sunshine Biopharma Announces Pricing of $5.0 Million Private Placement Priced At-the-MarketNASDAQ:SBFMSunshine Biopharma Inc
11/05/202323h00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:SBFMSunshine Biopharma Inc
11/05/202315h00GlobeNewswire Inc.Sunshine Biopharma Reports 2023 First Quarter Results: Revenues Up 2,100%NASDAQ:SBFMSunshine Biopharma Inc
10/05/202322h05Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:SBFMSunshine Biopharma Inc
05/04/202314h00GlobeNewswire Inc.Sunshine Biopharma Reports Full Year Ended December 31, 2022 Financial Results and Provides Corporate UpdateNASDAQ:SBFMSunshine Biopharma Inc
04/04/202312h10Edgar (US Regulatory)Annual Report (10-k)NASDAQ:SBFMSunshine Biopharma Inc
28/02/202313h30GlobeNewswire Inc.Sunshine Biopharma Signs Exclusive Worldwide License With University of Arizona For PLpro-Based Covid-19 TreatmentNASDAQ:SBFMSunshine Biopharma Inc
10/02/202313h35GlobeNewswire Inc.Sunshine Biopharma Signs Research Agreement With the Jewish General Hospital to Advance the Development of Adva-27a Anticancer CompoundNASDAQ:SBFMSunshine Biopharma Inc
19/01/202313h30GlobeNewswire Inc.Sunshine Biopharma Announces Share Repurchase ProgramNASDAQ:SBFMSunshine Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:SBFM

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
EU
RI
Pernod Ricard
NYSE
MCD
McDonalds
EU
BNP
BNP Paribas
EU
DG
Vinci
EU
HO
Thales
NYSE
JPM
JP Morgan Chase
EU
VIV
Vivendi
EU
PX4
SBF 120
COIN
ETHUSD
Ethereum
EU
AI
Air Liquide
COIN
BTCUSD
Bitcoin
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés